Skip to content

Net margin at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
15.2%+1.0pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
29.6%-2.3pp
AMP
Amphastar PharmaceuticalsAMPH
11%-8.4pp
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
4%+3.6pp
CorMedix logo
CorMedixCRMD
45.2%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
9.4%+2.8pp

Other financials

Income statement

See full
Revenue$156.1M-29.7%
Gross profit$84.1M-37.1%
Operating income$10.5M-79.0%
Net income$6.8M-90.0%
EPS (diluted)$0.07-94.1%

Balance sheet

See full
Cash & equivalents$161.5M+5.7%
Total debt$584.6M-13.1%
Total equity$523.1M-5.4%
Total assets$1.3B-7.4%

Cash flow

See full
Operating cash flow-$33.8M-202%
CapEx$2.4M-33.3%
Free cash flow-$36.2M-145%

Valuation

See full
Market cap$411.74M+22.0%
Enterprise value$834.84M-2.6%
P/E3.6×
P/S0.6×+0.3×

Profitability

See full
Gross margin54.2%+19.0pp
Operating margin15%+10.3pp
FCF margin20.8%

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.1×-0.1×
Current ratio4.3×-2.0×

Where this comes from

Calculated from Emergent Biosolutions’s reported figures.

Based on trailing twelve months.

The official record: Emergent Biosolutions’s 10-Q, filed October 30, 2025, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Emergent Biosolutions's net margin?
Emergent Biosolutions (EBS) reported net margin of 9.6% in Q3 2025.
How has Emergent Biosolutions's net margin changed year-over-year?
Emergent Biosolutions's net margin increased by 151.9% year-over-year, from -18.6% to 9.6%.
What is the long-term trend for Emergent Biosolutions's net margin?
Over 4 years (2020 to 2024), Emergent Biosolutions's net margin has grown at a -1.8% compound annual growth rate (CAGR), from 19.6% to -18.3%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.